Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Dr Reddy's launches generic SEROQUEL tablets in US

PBR Staff Writer Published 29 March 2012

Dr Reddy's Laboratories has launched Quetiapine fumarate tablets of strengths, 25mg, 50mg, 100mg, 200mg, 300mg and 400mg.

The launch of bioequivalent generic version of SEROQUEL tablets is followed by the FDA approval of Dr Reddy's ANDA.

Quetiapine fumarate tablets in 25mg and 50mg are available in 100 and 500 count bottle sizes, 100mg, 200mg and 400mg are available in 100 count bottle sizes and 300mg is available in 60 count bottle sizes.

The SEROQUEL brand had US sales of approximately $4.6bn for the most recent twelve months ending December 2011, according to IMS Health.

Comments
Post a comment

Comments may be moderated for spam, obscenities or defamation.